PUB051 TLR9 is Functional Marker for Cancer Stem Cell in Non-Small Cell Lung Cancer
F. Wu,S. Shan,Y. Han,Y. Wang,K. Wang,T. Ren
DOI: https://doi.org/10.1016/j.jtho.2017.09.1914
IF: 20.121
2017-01-01
Journal of Thoracic Oncology
Abstract:Accumulating evidence has proposed a model that tumorigenesis is driven by cancer stem cells (CSCs). Those CSCs are capable of sustaining self-renewal, developing into phenotypically diverse cancer cell populations, proliferating extensively and being resistant to treatment. Toll-like receptor 9 (TLR9) has been described to trigger innate and adaptive immune responses that may promote an antitumor immune response against cancers. Our previous data show that activation of TLR9 by CpG-ODN could activate IKK/NF-kB, MAPK/AP-1 and PI3K/Akt signal pathways. We also demonstrated that increased expression of TLR9 results in promoted migration, invasion and metastasis in lung cancer cells. Thus, as a cancer progression associated factor, TLR9 might also be involved in stem-cell function in cancer. We separated CSCs from cell lines and lung cancer tissues by CSC marker CD133 and ALDH. Then we knock down the expression of TLR9 and then investigate biological changes of CSCs, including sphere formation, self-renewing ability, invasion, resistance to drugs, and in vivo tumor formation. We found toll-like receptor (TLR9) are constitutively overexpressed on cancer stem cells (CSCs) derived from lung cancer cell lines and patients’ tissue when compared with non-stem cells. Knocking down of TLR9 in lung CSCs resulted in inhibited capacity for proliferation, invasion, tumorigenesis and resistance to chemotherapeutic drugs. Furthermore, cell cycle was arrested at G2/M stages and more apoptosis existed after TLR9 expression decreased. Further analysis indicated that TLR9 maintain the stemness of cancer cells by changing expression of other stem cell markers Gli1, Notch1 and beta-catenin, drug transporters ABCB1, ABCC1 and ABCG2 and anti-apoptotic factors BCL2 and Survivin. Of which, beta-catenin, was found to be most obviously related with TLR9 expression. Moreover, TLR9 expression was positively associated with tumor differentiation and inversely associated with lung cancer patient survival in clinic. Based on above data, TLR9 is crucial for marker and phenotype of lung CSC. It might work as a lung cancer stem cell maintainer.